DE60008073D1 - Furo[3,2-b]pyridine als 5-ht1f agonisten - Google Patents

Furo[3,2-b]pyridine als 5-ht1f agonisten

Info

Publication number
DE60008073D1
DE60008073D1 DE60008073T DE60008073T DE60008073D1 DE 60008073 D1 DE60008073 D1 DE 60008073D1 DE 60008073 T DE60008073 T DE 60008073T DE 60008073 T DE60008073 T DE 60008073T DE 60008073 D1 DE60008073 D1 DE 60008073D1
Authority
DE
Germany
Prior art keywords
furo
pyridines
ht1f agonists
ht1f
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60008073T
Other languages
English (en)
Other versions
DE60008073T2 (de
Inventor
Ann Filla
Michael Mathes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE60008073D1 publication Critical patent/DE60008073D1/de
Publication of DE60008073T2 publication Critical patent/DE60008073T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60008073T 1999-02-26 2000-02-11 Furo[3,2-b]pyridine als 5-ht1f agonisten Expired - Fee Related DE60008073T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12201699P 1999-02-26 1999-02-26
US122016P 1999-02-26
PCT/US2000/002505 WO2000050426A2 (en) 1999-02-26 2000-02-11 Furo[3, 2-b]pyridines as 5-ht1f agonists

Publications (2)

Publication Number Publication Date
DE60008073D1 true DE60008073D1 (de) 2004-03-11
DE60008073T2 DE60008073T2 (de) 2004-08-05

Family

ID=22400069

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60008073T Expired - Fee Related DE60008073T2 (de) 1999-02-26 2000-02-11 Furo[3,2-b]pyridine als 5-ht1f agonisten

Country Status (21)

Country Link
EP (1) EP1155020B1 (de)
JP (1) JP2002537398A (de)
KR (1) KR20010102355A (de)
AR (1) AR026856A1 (de)
AT (1) ATE258935T1 (de)
AU (1) AU3354000A (de)
BR (1) BR0008479A (de)
CA (1) CA2371784A1 (de)
CO (1) CO5150234A1 (de)
DE (1) DE60008073T2 (de)
EA (1) EA200100918A1 (de)
ES (1) ES2214256T3 (de)
HU (1) HUP0200245A2 (de)
ID (1) ID30056A (de)
IL (1) IL144355A0 (de)
NO (1) NO20014127D0 (de)
PE (1) PE20001432A1 (de)
PL (1) PL350864A1 (de)
TR (1) TR200102436T2 (de)
WO (1) WO2000050426A2 (de)
ZA (1) ZA200106109B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI263497B (en) 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
ES2388547T3 (es) 2003-04-18 2012-10-16 Eli Lilly And Company Compuestos de (piperidiniloxi)fenilo, (piperidiniloxi)piridinilo, (piperidinilsulfanil)fenilo y (piperidinilsulfanil)piridinilo como agonistas de 5-HT 1F
UA82711C2 (en) 2003-09-12 2008-05-12 Эли Лилли Энд Компани Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
ES2291978T3 (es) 2003-12-17 2008-03-01 Eli Lilly And Company Compuestos de (4-aminociclohexen-1-il)fenilo y (4-aminociclohexen-1-il)piridinilo sustituidos como agonistas de 5-ht1f.
US8697876B2 (en) 2010-04-02 2014-04-15 Colucid Pharmaceuticals, Inc. Compositions and methods of synthesis of pyridinolypiperidine 5-HT1F agonists
EP2940022B1 (de) * 2014-04-30 2020-09-02 Masarykova Univerzita Furopyridinen als Inhibitoren von Proteinkinasen
TWI776175B (zh) 2019-07-09 2022-09-01 美商美國禮來大藥廠 大規模製備2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺半琥珀酸鹽的方法及中間體，以及2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺醋酸鹽之製備

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1184425A (zh) * 1995-03-20 1998-06-10 伊莱利利公司 5－取代－3－(1,2,3,6－四氢吡啶－4－基)－和3－(哌啶－4－基)－1h－吲哚:新型5－ht1f激动剂
FR2732969B1 (fr) * 1995-04-14 1997-05-16 Adir Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO1998011895A1 (en) * 1996-09-18 1998-03-26 Eli Lilly And Company A method for the prevention of migraine

Also Published As

Publication number Publication date
EP1155020B1 (de) 2004-02-04
KR20010102355A (ko) 2001-11-15
EP1155020A2 (de) 2001-11-21
JP2002537398A (ja) 2002-11-05
ES2214256T3 (es) 2004-09-16
NO20014127L (no) 2001-08-24
ATE258935T1 (de) 2004-02-15
ZA200106109B (en) 2002-07-25
DE60008073T2 (de) 2004-08-05
AU3354000A (en) 2000-09-14
IL144355A0 (en) 2002-05-23
HUP0200245A2 (en) 2002-06-29
ID30056A (id) 2001-11-01
EA200100918A1 (ru) 2002-02-28
PE20001432A1 (es) 2000-12-18
TR200102436T2 (tr) 2002-06-21
WO2000050426A3 (en) 2000-12-21
CA2371784A1 (en) 2000-08-31
NO20014127D0 (no) 2001-08-24
AR026856A1 (es) 2003-03-05
CO5150234A1 (es) 2002-04-29
WO2000050426A2 (en) 2000-08-31
PL350864A1 (en) 2003-02-10
BR0008479A (pt) 2002-01-29

Similar Documents

Publication Publication Date Title
DE60202200D1 (de) Imidazo[1,2-a]-pyridinderivate als mglur5 antagonisten
HRP20030306A2 (en) Pyridine derivatives with ikb-kinase (ikk-?) inhibiting activity
PT1218378E (pt) Derivados de terc-butil-(7-metil-imidazo-¬1,2-a|-piridin-3-il)-amina
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
EE04964B1 (et) Imidaso[1,2a]pridiini ja prasolo[2,3a]pridiiniderivaadid
NO20013384D0 (no) Imidazo[4,5-c]pyridin-4-on-derivater
DE69824872D1 (de) 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridin derivate
DE60008073D1 (de) Furo[3,2-b]pyridine als 5-ht1f agonisten
NO20005485D0 (no) Orale preparater inneholdende 8-klor-6,11-dihydro-11-(4- piperyliden)-5H-benzo-[5,6]syklohepta[1,2-b]pyridin
AU2003230758A1 (en) 5h-benzo(4,5)cyclohepta(1,2-b)pyridine nmda/nr2b antagonists
NO20004906D0 (no) PDE IV-inhiberende pyridinderivater
DE60001054D1 (de) Trizyclische pyridin n-oxide vasopressin agonisten
AU7845701A (en) Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
AU2001278457A1 (en) Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
NO20004892D0 (no) Kinolin-4-yl-derivater I
DK1088818T3 (da) Quinolin-4-yl-derivater
ATE363485T1 (de) Benzothieno(3,2-c)pyridine als alpha2- antagonisten
PT1192163E (pt) Ditiepino¬6,5-b|piridinas e composicoes e metodos relacionados
EE04372B1 (et) 5-asendatud-3-oksadiasolüül-1,6-naftüridiin-2(1H)-ooni derivaadid
EP1359912A4 (de) Neue verfahren zur anwendung von pyridinderivaten
DE69807477D1 (de) Benzo[5,6]cyclohepta[1,2-b]pyridine derivate als farnesyl protein transferase inhibitoren
PL347999A1 (en) Novel derivative of pyrrole [3,4-c] pyridine or 3,4-pyridine dicarboxylimide
PL342083A1 (en) Novel derivative of pyrrole[3,4-c]pyridine or 3,4-pyridine dicarboxyimide
PL342084A1 (en) Novel derivative of pyrrole[3,4-c]pyridine or 3,4-pyridine dicarboxyimide
DE29906593U1 (de) Schwenktüre

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee